Medicare Enrolled
Dr. Ehab Hanna, MD
Internal Medicine · Crowley, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hanna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hanna
Dr. Ehab Hanna is an internal medicine specialist in Crowley, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hanna performed 7,654 Medicare services across 3,758 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hanna received a total of $9,252 from 75 pharmaceutical and/or device companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hanna is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in TX
$9,252 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,654
Medicare services
Top 4% in TX for internal medicine
3,758
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~425 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 599 | $47 | $90 |
| Office visit, established patient (30-39 min) | 476 | $93 | $166 |
| Blood draw (venipuncture) | 364 | $8 | $10 |
| Comprehensive metabolic blood panel | 357 | $10 | $65 |
| Ceftriaxone antibiotic injection | 348 | $0 | $25 |
| Complete blood count (CBC) with differential | 338 | $8 | $25 |
| Magnesium level test | 303 | $7 | $27 |
| C-reactive protein test (inflammation marker) | 272 | $5 | $75 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 213 | $96 | $150 |
| Electrocardiogram (EKG), 12-lead | 204 | $11 | $34 |
| Dexamethasone injection (steroid) | 200 | $0 | $20 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 185 | $54 | $95 |
| Drug injection, under skin or into muscle | 183 | $11 | $48 |
| Office visit, established patient (20-29 min) | 176 | $59 | $146 |
| Natriuretic peptide (heart and blood vessel protein) level | 152 | $38 | $50 |
| Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | 149 | $44 | $100 |
| Creatine kinase (cardiac enzyme) level, total | 145 | $6 | $50 |
| Creatine kinase (cardiac enzyme) level, mb fraction only | 143 | $11 | $50 |
| Hemoglobin A1c test (diabetes monitoring) | 138 | $10 | $31 |
| Thyroid stimulating hormone (TSH) test | 130 | $16 | $50 |
| Free thyroxine (T4) test | 124 | $9 | $25 |
| Lipid panel (cholesterol and triglycerides) | 123 | $13 | $60 |
| Thyroid hormone, t3 measurement, free | 121 | $16 | $50 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 114 | $40 | $250 |
| Automated urinalysis | 103 | $2 | $15 |
| Vitamin D level test | 102 | $29 | $89 |
| Parathyroid hormone level test | 102 | $40 | $75 |
| Urine microalbumin test (kidney screening) | 85 | $6 | $75 |
| Testing of autonomic (sympathetic) nervous system function | 81 | $96 | $360 |
| Vitamin B-12 level test | 80 | $15 | $60 |
| Testosterone (hormone) level, total | 77 | $25 | $89 |
| Uric acid level test | 73 | $4 | $21 |
| Complete ultrasound study of arm and leg arteries | 72 | $102 | $260 |
| Amylase (enzyme) level | 67 | $6 | $27 |
| Test to measure expiratory airflow and volume | 62 | $21 | $68 |
| Folic acid level test | 61 | $14 | $52 |
| Iron level test | 60 | $6 | $27 |
| Lipase (fat enzyme) level | 60 | $7 | $50 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 60 | $34 | $100 |
| Chronic care management, additional 20 min/month | 60 | $37 | $75 |
| Multiple measurements of eye fluid pressure over an extended time period | 54 | $67 | $150 |
| Measurement of total estradiol (hormone) | 52 | $27 | $85 |
| Creatinine test (kidney function) | 48 | $5 | $75 |
| Telephone medical discussion with physician, 5-10 minutes | 47 | $44 | $75 |
| Rheumatoid factor level | 43 | $6 | $50 |
| Annual wellness visit, follow-up | 42 | $128 | $235 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $71 | $250 |
| Testing for presence of drug, read by direct observation | 39 | $12 | $25 |
| Cortisol (hormone) measurement, total | 38 | $16 | $100 |
| Carcinoembryonic antigen (cea) protein level | 32 | $19 | $85 |
| Breath test analysis for helicobacter pylori | 31 | $66 | $150 |
| Administration of drug for helicobacter pylori | 30 | $8 | $150 |
| Urine culture, bacterial colony count | 30 | $8 | $45 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 27 | $74 | $350 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 27 | $24 | $100 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 26 | $41 | $104 |
| Bacterial culture, any other source except urine, blood or stool, aerobic | 25 | $8 | $100 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 25 | $140 | $300 |
| Retinal photography (fundus photo) | 25 | $21 | $194 |
| Troponin (protein) analysis, quantitative | 24 | $12 | $125 |
| Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 23 | $124 | $368 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 23 | $1 | $20 |
| Lactic acid level | 22 | $11 | $50 |
| PSA test (prostate cancer screening) | 20 | $18 | $53 |
| Flu vaccine administration | 18 | $30 | $75 |
| Annual depression screening | 15 | $18 | $35 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 14 | $16 | $50 |
| Assessment of emotional or behavioral problems | 14 | $4 | $45 |
| Flu vaccine, high-dose | 13 | $72 | $75 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $101 | $160 |
| Prostate cancer screening; prostate specific antigen test (psa) | 11 | $19 | $53 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,252
Total received (2018-2024)
Avg $1,322/year across 7 years
Top 9% in TX for internal medicine
75
Companies
531
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,218 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,390
2023
$1,378
2022
$1,938
2021
$2,202
2020
$871
2019
$698
2018
$775
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,695
ABBVIE INC.
$591
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$583
Novo Nordisk Inc
$566
PFIZER INC.
$463
Lilly USA, LLC
$453
AbbVie Inc.
$388
GlaxoSmithKline, LLC.
$373
Bayer HealthCare Pharmaceuticals Inc.
$335
Corcept Therapeutics
$314
Novartis Pharmaceuticals Corporation
$251
Amgen Inc.
$251
Dexcom, Inc.
$172
Sunovion Pharmaceuticals Inc.
$171
Stryker Corporation
$162
Supernus Pharmaceuticals, Inc.
$158
Eisai Inc.
$130
SANOFI-AVENTIS U.S. LLC
$121
JAZZ PHARMACEUTICALS INC.
$108
DEXCOM, INC.
$101
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
GENZYME CORPORATION
$98
Janssen Pharmaceuticals, Inc
$94
Bayer Healthcare Pharmaceuticals Inc.
$83
Radius Health, Inc.
$74
Teva Pharmaceuticals USA, Inc.
$74
Abbott Laboratories
$67
Shield Therapeutics Inc
$67
Sumitomo Pharma America, Inc.
$55
Otsuka America Pharmaceutical, Inc.
$53
Inspire Medical Systems, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$53
Xeris Pharmaceuticals, Inc.
$52
Merck Sharp & Dohme Corporation
$47
Takeda Pharmaceuticals U.S.A., Inc.
$41
Optinose US, Inc.
$38
Jazz Pharmaceuticals Inc.
$38
Merck Sharp & Dohme LLC
$38
BOSTON SCIENTIFIC CORPORATION
$35
Exact Sciences Corporation
$35
Mylan Specialty L.P.
$34
Bolton Medical Inc
$32
Horizon Therapeutics plc
$32
SHIELD THERAPEUTICS INC
$32
RedHill Biopharma Inc.
$28
Cumberland Pharmaceuticals, Inc.
$27
IBSA Pharma Inc.
$26
Antares Pharma, Inc.
$25
Biogen, Inc.
$25
Astellas Pharma US Inc
$23
ITI, Inc.
$21
Paratek Pharmaceuticals, Inc.
$21
Nevro Corp.
$21
Philips North America LLC
$19
Alnylam Pharmaceuticals Inc.
$19
HARMONY BIOSCIENCES LLC
$19
Harmony Biosciences LLC
$18
SCILEX PHARMACEUTICALS INC.
$18
Ultragenyx Pharmaceutical Inc.
$18
Amarin Pharma Inc.
$18
Tactile Systems Technology Inc
$17
Nestle HealthCare Nutrition Inc.
$16
Esperion Therapeutics, Inc.
$15
Philips Electronics North America Corporation
$15
Currax Pharmaceuticals LLC
$14
Biohaven Pharmaceutical Holding Company Ltd.
$14
Alvogen Inc
$14
Strongbridge US INC.
$13
Renalytix AI, Inc.
$13
SANOFI PASTEUR INC.
$13
Nabriva Therapeutics, plc
$12
Genentech USA, Inc.
$12
Sanofi Pasteur Inc.
$11
Horizon Pharma plc
$11
Metacel Pharmaceuticals LLC
$10
Top 3 companies account for 31.0% of total payments
Associated products mentioned in payments ›
(CK7) Extended Holter · ABILIFY MAINTENA · ACCRUFER · ADUHELM · AIMOVIG · AIRSUPRA · AJOVY · Aemcolo · Aimovig · BASAGLAR · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CORE · CREON · Cologuard Collection Kit · DALIRESP · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIFICID · DUEXIS · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · Flexitouch Plus · GEMTESA · GIVLAARI · GLASSIA · GVOKE HYPOPEN · INSPIRE · INVEGA SUSTENNA · JANUVIA · JARDIANCE · KEVEYIS · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · Kristalose · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · NUZYRA · OFEV · OXTELLAR XR · Omeclamox · Otezla · Ozempic · Ozobax · PENNSAID · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · RAYOS · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPRAVATO · STEGLATRO · SUNOSI · SYMBICORT · Saxenda · Senza Spinal Cord Stimulation System · Superion · TERIPARATIDE · TOUJEO · TRELEGY ELLIPTA · TREO ABDOMINAL STENT-GRAFT SYSTEM · TRULANCE · TRULICITY · TZIELD · Talicia · Tirosint · Tresiba · Tymlos · UBRELVY · Utibron · VIBERZI · VRAYLAR · Vascepa · Victoza · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XIFAXAN · XYOSTED · XYREM · Xenleta · Xhance · Xofluza · Xyrem · YUPELRI · Yupelri · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in TX.
Equivalent to $121 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
682
Per 100K population
31.9
County median income
$81,905
Nearest hospital
MESA SPRINGS
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hanna is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement in the top 9% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hanna experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Hanna performed 599 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hanna receive payments from pharmaceutical companies?
Yes. Dr. Hanna received a total of $9,252 from 75 companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hanna's costs compare to other internal medicine physicians in Crowley?
Dr. Hanna's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hanna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Crowley
Browse internal medicine physicians in Crowley ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology